• Luis Margusino-Framiñán, Aitziber Illarro-Uranga, Karina Lorenzo-Lorenzo, Emilio Monte-Boquet, Esther Márquez-Saavedra, Noelia Fernández-Bargiela, David Gómez-Gómez, Natividad Lago-Rivero, José Luis Poveda-Andrés, Rocío Díaz-Acedo, Juan Luis Hurtado-Bouza, Julia Sánchez-Gundín, Cristina Casanova-Martínez, and Ramón Morillo-Verdugo.
• Servicio de Farmacia, Complejo Hospitalario Universitario, A Coruña. España. Luis.margusino.framinan@sergas.es.
• Farm Hosp. 2020 Jun 13; 44 (7): 61-65.

AbstractHospital Pharmacy Service (HPS) in Spain have been impacted by the health  crisis caused by the COVID-19 pandemic. Thus, the outbreak has forced HPSs to adapt their outpatient consultation services to Telepharmacy to optimize clinical  outcomes and reduce the risk of contagion. The purpose of this article is to  describe and analyze the experience of HPSs with outpatient Telepharmacy  during the COVID-19 pandemic and expose the lessons learned. Measures have  been adopted in on-site outpatient pharmacy clinics to prevent exposure of  patients and professionals to the virus. These measures are based on national  and international recommendations on social distancing and hygiene. With  regard to remote outpatient pharmacy services, teleconsultation with drug  dispensing has been promoted based on five basic procedures, each with its  advantages and limitations: home drug delivery from HPSs, with the advantage  of universal access and the limitation of entailing a substantial investment in  resources; HPS coordination with primary care pharmacists, which requires no  investments but with limited access to some geographic areas; HPS coordination with community pharmacists based on a large network of pharmacies, which  requires the patient to go to the pharmacy, without confidentiality being  guaranteed for any patient; geolocation and hospital-based medication  dispensing, which provides universal access and direct traceability, but entails  investment in human resources; and HPS coordination with associations of  patients, which does not entail any additional cost but limits the information  available on the diseases of society members. Three main lessons have been learned during the pandemic: the satisfactory capacity of HPS to provide outpatient pharmacy consultation services in the setting of a public health crisis; the usefulness of Telepharmacy for the clinical follow-up, healthcare coordination, outpatient counseling, and informed dispensing and delivery of  medication (with a high level of satisfaction among patients); and the need to  foster Telepharmacy as a complementary tool through a mixed model of  outpatient pharmacy consultation service that incorporates the advantages of  each procedure and adapts to the individual needs of each patient in a context of humanized healthcare.Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

35 keywords...

hide…